DRI Cocaine Metabolite Assay

DRI Cocaine Metabolite Assay is an FDA 510(k)-cleared medical device (K211973) manufactured by Microgenics Corporation. This device is classified under the Clinical Toxicology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 23, 2021. Regulation: 8.